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Precursor antibody-forming cells (AFC)' are those bone marrow-derived (B) lymphocytes
that are committed to follow several terminal pathways . Precursor cells can respond to
antigen by proliferation and maturation to AFC (induction), or by inactivation in that
cells are rendered noninducible (paralysis) . Haptens coupled to immunogenic carriers
elicit hapten-specific immune responses in animals, but haptens on nonimmunogenic
carriers do not (1-7) . Haptens on nonimmunogenic carriers are not inert because they
induce a hapten-specific unresponsiveness which is due to a direct inactivation of the
precursors of AFC, and not to an indirect suppressive event (1, 4-8) . Since haptens on
nonimmunogenic carriers inactivate precursor cells in the absence of thymus-derived (T)
cells, the interaction between haptens and immunoglobulin receptors on the surface of
precursor cells is sufficient to initiate the intracellular events that constitute the paralytic
pathway. A number of haptens on nonimmunogenic carriers have been shown to elicit
hapten-specific immune responses when a T-cell signal acting on precursor cells is
provided by allogeneic lymphoid cells (4, 6, 8) or by bacterial lipopolysaccharides (LPS)
(9, 10), implying that the T-cell signal diverts those cells binding hapten from a paralytic
to an inductive pathway. These experiments also suggest that the inductive stimulus is
delivered to precursor cells via two membrane-mediated events: the first by the binding of
haptenic determinants to surface immunoglobulin receptors and the second by a T-cell
signal acting on precursor cells. However, it is not known whether the intracellular
changes initiated by hapten binding are required for both inductive and paralytic
pathways (11), or whether the changes initiated in precursor cells by the T-cell signal
alone are sufficient to induce maturation to AFC (12, 13).
The experiments described here question the possible involvement of the cyclic
nucleotides, adenosine and guanosine 3',5'-cyclic monophosphates as the intra-
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cellular mediators of the membrane-mediated signals that regulate the inductive
and paralytic pathways in precursor cells. These two cyclic nucleotides have
ubiquitous effects on the proliferation (14-23) and differentiation (24-26) of
mammalian cells. The addition of mitogenic concentrations of LPS to mouse
spleen cultures is shown here to transiently increase intracellular levels of
guanosine 3',5'-cyclic monophosphate (cyclic GMP) but not adenosine 3',5'-
cyclic monophosphate (cyclic AMP) . In addition, cyclic GMP itself is shown to
have mitogenic properties. An analysis of a number of mammalian cell
populations indicates that the intracellular ratios of cyclic AMP to cyclic GMP
are consistently lower in dividing cells compared to nondividing cells. Agents
that interact with lymphoid cells to increase intracellular levels of cyclic AMP
inhibit the proliferative response of B lymphocytes to LPS. The effects of raising
intracellular levels of cyclic nucleotides on the induction of in vitro immune
responses to erythrocyte antigens have been described elsewhere (14, 15) . LPS
and cyclic GMP enhance immune responses in T-cell-depleted cultures (14) .
These results lead to the suggestion that antigen raises intracellular levels of
cyclic AMP and T-helper cells (and LPS) function by raising intracellular cyclic
GMP levels, and that it is the intracellular ratio of cyclic AMP to cyclic GMP
which determines the pathway a precursor AFC follows.
Materials and Methods
Mice.
￿
C57BL/6 mice were purchased from Jackson Laboratories, Bar Harbor, Maine. Congeni-
tally athymic (nude) mice (H-2°) were bred at the Salk Institute, San Diego, Calif. (27) .
Chemicals .
￿
The chemical agents utilized in this study are indicated as follows : carbamylcholine
chloride (carbachol) and D-L isoproterenol hydrochloride from Sigma Chemical Co., St . Louis, MO. ;
N°,02 dibutyryl adenosine 3',5'-cyclic monophosphate (dibutyryl cyclic AMP), cyclic AMP,
adenosine 5'-monophosphate (5' AMP), N6,0='-dibutyryl guanosine 3',5'-cyclic monophosphate
(dibutyryl cyclic GMP), cyclic GMP, and guanosine 5'-monophosphate (5' GMP), all sodium salts,
from Plenum Scientific Company, NewYork. Escherichia coli 0127:138 LPS wasobtained from Difco
Laboratories, Detroit, Mich.
Spleen Cell Cultures.
￿
Immune responses to sheep erythrocytes (SRBC) were studied in spleen
cultures prepared from C57BL/6 or nude mice exactly as detailed elsewhere (27, 28). Cells were
cultured at a starting density of 10' cells/ml. The number of hemolytic plaque-forming cells (PFC)
was determined on day 4 and has been calculated as the number of PFC per 106 recovered cells (27,
28) .
To study polyclonal responses, spleen cultures were incubated for 3 days with various concentra-
tions of LPS. The increase in AFC specific for trinitrophenyl (TNP) was used as the assay for a
polyclonal response. Each spleen culture was assayed in a hemolytic plaque assay using SRBC or
TNP coupled to SRBC as target cells (29) . The difference in PFC detected using SRBC and
TNP-SRBC in the plaque assay has been reported as the TNP-specific AFC.
Mitogenic responses were also assayed in nude spleen cultures. The chemical agents designated in
the test were added in 0.1-ml vol dissolved in a balanced salt solution (BSS) to 1-ml cultures. The
cultures were incubated for 24 h and then incubated for an additional 6 h with 10-' M
fluorodeoxyuridine, 10-6 M thymidine, and 0.5 pCi['H]thymidine (52 Ci/mmol; New England
Nuclear, Boston, Mass .) . Cells were then collected by membrane filtration (Whatman GF/c), and
were washed successively with 10-vol of BSS, 10%TCA, and 95`7, alcohol. Filters were dried and then
radioactive measurements were made.
Autoradiography was performed as described elsewhere (30) . Only those cells with more than 20
grains were counted as labeled. Approximately 1,000 cells were counted in each assay to determine
the percentage of labeled cells .
Cyclic Nucleotide Measurements .
￿
Nude spleen cells were seeded at a density of 2 x 10' cells/mlJAMES WATSON
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in Eagle's medium supplemented with 5% fetal bovine serum, left 16 h after preparation, and then
various agents added for the periods described in the text. Four to eight cultures were pooled, mixed
with 0.1 vol of 50% TCA, and boiled. Samples were centrifuged at 10,000 gfor20 min., thesupernates
removed and extracted with ether, then lyophilized to dryness. The dry residues were then dissolved
in 1.0 ml of 0.1 M Tris-HCI buffer (pH8.5) containing 0.5 mM MgCl, and separated into two 0.5-ml
samples. One sample was treated with 5 jug 3',5'-cyclic nucleotide phosphodiesterase (Sigma
Chemical Co.), to check the authenticity of the products assayed (31) and then both treated and
untreatedsamples were separately mixed with 1-2 ml Dowex resin (Bio-Rad AG 1-X8, 200-400 mesh,
formate form, Bio-Rad Laboratories, Richmond, Calif.), and the cyclic AMP and cyclic GMP
fractions eluted with 2 N and4N formic acid, respectively. Solutions were lyophilized to drynessand
redissolved in 0.05 M sodium acetate (pH 6.2). Both cyclic AMP and cyclic GMP were measured
using the radioimmune assay of Steiner et al. (32) purchased in assay kits from Collaborative
Research, Boston, Mass . The cyclic nucleotide measurements for the enzyme-treated samples have
been subtracted from the data presented. Radioactive cyclic nucleotide markers were added to
control cultures at the start of extractions to check therecovery of each cyclic nucleotide. In general,
recoveries of radioactive cyclic AMP and cyclic GMP were between 63% and 70%. These radioactive
markers were chromatographed as described below to check that the recovered material was
undegraded. Dowex resins were washed andrecycled before use.
The results obtained with the radioimmune assay were then checked using a radioactive labeling
procedureto measureintracellular changesin levels ofcyclic AMP andcyclic GMP. Nude spleen cells
were radioactively labeled with 20 uCi/ml ["P]H,PO, for 10-20h. The agents indicated in the text
were then added and cyclic AMP and cyclic GMP were isolated 15 min later as described above.
Approximately 2 x 10' cpm/10' of '2P-labeled acid soluble material was recovered after the initial
TCA extraction. After chromatography over Dowex AG 1-X8 columns, cyclic AMP- and cyclic
GMP-containing fractions were lyophilized and dissolved in 0.1 M ammonium acetate (pH 7.0) .
Samples were applied to Whatman 3MM paper and the chromatogram developed in a solvent of
butanol:acetone:0.5 M ammonium acetate pH 7.0 (7:5:8) for 30-40h. The chromatogram was dried
and cut into strips of 32P-labeled cyclic AMP and cyclic GMP. Radioactivity in the cyclic nucleotide
regions were recorded for duplicate experiments which agreed to within 20%.
Results
Effect of LPS on Intracellular Cyclic Nucleotide Levels . The effect of
mitogenic concentrations of LPS on intracellular cyclic nucleotide levels has
been examined in mouse spleen cultures. The addition of 25 Ng E. coli 0127 :B8
LPS to nude mouse spleen cultures results in a rapid, transient elevation of
intracellular levels of cyclic GMP (Fig. 1) . Maximum stimulation generally
occurs between 5 and 20 min after the addition of LPS to cultures. In general,
considerable variation in the magnitude of the elevation of cyclic GMP levels is
observed in different experiments . These increases are consistently in the range
of threefold to fivefold above background values obtained in nonstimulated
cultures . The intracellular levels of cyclic GMP then decrease to a level which is
generally slightly higher than the initial background value. In contrast to these
rapid changes in the intracellular levels of cyclic GMP little change in cyclic
AMP levels is observed. In some experiments a transient decrease in cyclic AMP
levels has been observed within 30 min after LPS addition to cultures.
To verify the results obtained with the radioimmune assay procedure,
experiments were performed to measure cyclic nucleotide levels in spleen cells
utilizing a radioactive-labeling procedure . Spleen cells were labeled with
[32P]H,PO, for 12 h and then 25 Mg LPS was added to each culture. After 15 min,
acid soluble material was isolated and cyclic AMP and cyclic GMP recovered
from samples . Each cyclic nucleotide preparation was cochromatographed with100
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Effect of LPS on intracellular levels of cyclic AMP (CAMP) and cyclic GMP (cGMP).
Nude spleen cells were cultured at a density of 10' cells/ml and left 16-20 h. Then 25 jug E. coli
0127:138 LPS was added to each culture for thetimes indicated, cyclic AMP and cyclic GMP
extracted from the cells, and measured using a radioimmune assay procedure (32) . For DNA
synthetic responses, ['Hithymidine was added to cultures at the time shown, and after 4-h
incubation incorporation was measured as described in the Materials and Methods. While in
the above experiment the ratio of cyclic AMP to cyclic GMP at the start was 6.0, in most ex-
periments this ratio in resting cells has varied between 9.0 and 20.0.
radioactive markers to separate cyclic AMP and cyclic GMP from their
respective precursor nucleotides and the total radioactivity associated with
specific cyclic nucleotide regions determined (Table 1) . The total radioactivity
associated with cyclic GMP consistently increased by 15-20 min after LPS
stimulation to fourfold above the values obtained in nonstimulated cultures
(Table 1), while smaller changes in the radioactivity associated with cyclic AMP
were observed . The comparison of 32P-labeled counts per minute of cyclic AMP
and cyclic GMP do not reflect their relative concentrations in the cell as the
intracellular specific activities of their precursor molecules (ATP, and GTP) are
different for a 12 h labeling period.
The initiation of DNA synthesis is not detected until 12-14 hafter the addition
of LPS to cultures . The question arises then as to how a transient early change in
the intracellular level of cyclic GMP can function as a mitogenic signal. The data
shown in Table 11 compare intracellular levels of cyclic AMP and cyclic GMP in
spleen cells to those in other cells. Nude spleen cells cultured in the absence of
LPS show a basal level of 0.4 t 0.2 pmol/106 cells for cyclic AMP and 0.05 ::E 0.03
pmol/106 cells for cyclic GMP (Table 11) and less than 1% of these cells show
significant incorporation of radioactive thymidine into nuclei (Table 11). The
ratio of cyclic AMP to cyclic GMP varies in resting cells in the range of 9.0-20.0.
24 h after the addition of LPS to cultures 16-20% of cells show increased DNA
synthetic activity (Table 11), and while the levels of both cyclic nucleotides have
increased, the ratio of cyclic AMP to cyclic GMP has generally fallen below 5.0.
This change towards a lower ratio is continued in cultures examined at 48 h
where the number of dividing cells are in the range of 30-42% . For comparative
purposes the intracellular concentrations of cyclic AMP and cyclic GMP have
been examined in nondividing and dividing 3T3 cultures . While the absoluteJAMES WATSON
TABLE I
The Incorporation of [32P]H,PO, into Cyclic GMP in Spleen
Cultures
Nude spleen cellswere seeded at adensity of 10' cells/ml and radioactively
labeled with 20 ACi/ml [32P]H,P0, for 10-12 h. At that time 25 Ag E. coli
0127:B8 LPS was added and cyclic AMP and cyclic GMPwere isolated 15
min and 20 min later. Approximately 2 x 10' cpm 10' cells of 31P-labeled
acid soluble material was recovered after the initial TCA extraction .
Samples were chromatographedover Dowex AG 1-X8 columnsto separate
cyclic AMP from cyclic GMP and the counts per minute associated with
each cyclic nucleotide determined by paper chromatography (see Mate-
rials andMethods) . The counts per minute in thecyclic nucleotide regions
were recorded for duplicate experiments and agree to within 20%.
TABLE II
Intracellular Levels of Cyclic AMP and Cyclic GMP in VariousNondividing and Dividing
Cell Cultures
Nude spleen cells were cultured at a density of 10' cells/ml and after 16 h treated with LPS for the
times indicated. RAW-8 and P3 tumor cells were used at a density of 108 cells/ml. 3T3 cells were
grown in Eagle's medium supplemented with 10% horse serum and used during growth or after
cultures had incubated in medium lacking serum for 16 h. Parallel cultures were incubated with
radioactive thymidine for 10 h as described in the Materials and Methods and then examined by
autoradiographic techniques to determine how many cells were active in DNA synthesis. The tumor
cells were provided by Dr. P. Ralph, Salk Institute, San Diego, Calif., and the conditions for
maintaining cells in culture have been described elsewhere (33) .
Cells Labeled
nuclei
pmol/108
CAMP
cells
cGMP
cAMP/cGMP
%
Nude spleen control 1.0 0.46 0.05 9.2
Nude spleen + 25 jug LPS
At 24 h 16 0.96 0.28 3.4
At 48 h 36 0.70 0.32 2.1
3T3 (minus serum) 2.1 8.6 0.54 15.9
3T3plus 10%horse serum 54 3.2 0.94 3.4
P3 plus 10% horseserum 62 5.2 3.6 1.4
S49 plus 10% horseserum 64 1.09 0.96 1.1
RAW-8plus 10%horse serum 71 2.5 2.8 0.89
Treatment
"P-labeled
Cyclic AMP
counts per minute
Cyclic GMP
None 19,800 46,500
25 Ag LPS (15min) 24,600 93,200
25 Ag LPS (20min) 26,700 124,200102
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levels of cyclic AMP and cyclic GMP in 3T3 cells is higher than spleen cells, the
ratio of these two cyclic nucleotides is always high ( > 10) in nondividing cells and
much lower ( <4) in dividing cultures. Also, the cyclic AMP to cyclic GMP ratio
in rapidly growing lymphoid (P3 and S49) and myeloid (RAW-8) tumor cells is
always low (0.8-2.0) (Table 11). The data show that the intracellular ratio of
cyclic AMP and cyclic GMP is very different in nondividing and dividing
mammalian cells and raise the question of whether a mitogenic signal delivered
by LPS is read by B cells as a change in the absolute level of cyclic GMP or a
change in ratio of cyclic AMP to cyclic GMP.
Effects of Cyclic Nucleotides on LPS Actiuity . LPS exerts several major
effects in mouse spleen cultures : LPS induces DNA synthesis in most B
lymphocytes and causes their maturation to AFC cells which can be measured by
an increase background immune response to a wide variety of determinants
termed the polyclonal response (12, 13, 27, 28) . Lower LPS concentrations also
stimulate immune responses to a variety ofantigenic determinants presented in
nonimmunogenic forms. This can be done by using heterologous erythrocyte
antigens in T-cell-depleted cultures. The data presented in Table III compare the
effects of exogenously added cyclic nucleotides or drugs which increase intracel-
lular levels of cyclic nucleotides, on each of these three responses to LPS in nude
spleen cultures. Dibutyryl cyclic AMP and isoproterenol, a beta-adrenergic
agonist which increases cyclic AMP levels (14, 34, 35) but not 5' AMP inhibited
the mitogenic, polyclonal, and inductive effects of LPS. Cyclic GMP and
carbachol, a cholinergic agonist which increases cyclic GMP levels (14, 34, 35)
showed little effect (Table III). Raising intracellular levels of cyclic AMP
therefore appears to inhibit the events which are normally a consequence of
LPS-induced cell proliferation.
The effect of isoproterenol and carbachol on intracellular cyclic AMP and
cyclic GMP levels in nude spleen cultures is described elsewhere (14). Iso-
proterenol stimulates increases in intracellular levels of cyclic AMP but not
cyclic GMP. Conversely, carbachol enhances intracellular levels of cyclic GMP
without changing markedly cyclic AMPlevels (14). An attempt was also made to
measure intracellular cyclic AMP and cyclic GMP levels after the addition of
exogenous dibutyryl cyclic AMP and cyclic GMP to spleen cultures . This
procedure was unsuitable for measuring intracellular changes after the addition
of cyclic nucleotides to cells in culture because of extracellular binding to cell
surfaces (data not presented) .
Cyclic Nucleotides and the Initiation of DNA Synthesis.
￿
The effect of cyclic
AMP and cyclic GMP on the initiation of DNA synthesis in nude spleen cultures
is shown in Table IV. Cyclic GMP and its butyrated derivatives all stimulate
DNA synthesis in nude spleen cultures in concentrations ofbetween 10' M and
10-3 M. The magnitude of the stimulation after 24 h varies in different
experiments in the range ofthreefold to fivefold. After 48 h and 72 h, cyclic GMP
shows little enhancement of DNA synthesis in mouse spleen cultures (Fig. 2) .
The effects of other guanosine nucleotides. 5' GMP (Table IV) and 2',3' GMP
(not shown), have shown quite variable effects upon DNA synthetic responses.
Both nucleotides have shown stimulatory effects as shown for 5' GMP in Table
IV in many experiments. Carbachol has no detectable mitogenic effects. Also,JAMES WATSON
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TABLE III
Effect of Cyclic AMPand Cyclic GMP Eleuating Agents on LPS Actiuity
E. coli 0127:138 LPS was used at a concentration of 10 jAg/ml in nude spleen cultures seeded at an
initial density of 107 cells/ml . On day3, the incorporation of'radioactive thymidine was measured as
described in the Materials and Methods. The polyclonal response was measured in parallel cultures
by determining the number of PFC directed against TNP. To measure the induced or antigen-
dependent response to SRBC, nude spleen cultures were seeded with LPS as indicated t 3 x 106
SRBC. On day 4 the number of PFC directed against SRBC was determined . Each figure represents
the mean of triplicate cultures.
cyclic AMP, its butyrated derivatives, and isoproterenol have no stimulatory ef-
fect on DNA synthesis in nude spleen cultures in concentrations between 10-s
M and 10-3 M. At high concentrations all of these cyclic AMP-elevating agents
have marked inhibitory effects on the incorporation of radioactive thymidine in
spleen cultures.
The stimulation of DNA synthesis by cyclic GMP in spleen cultures was also
examined by autoradiographic techniques . When spleen cultures were incubated
for 24 h with various concentrations of cyclic GMP (1 x 10-'M-1 x 10 -'M) and
then labeled with radioactive thymidine for 6 h, between 5% and 10% of the cells
showed labeled nuclei (Table V) . This shows that cyclic GMP itself stimulates
significant numbers of lymphocytes into DNA synthesis.
Effect of Cyclic Nucleotides on Immune Responses. It has been shown
elsewhere that the addition of cyclic AMP or agents known to stimulate increases
Nude spleen cells
+ 10 kg LPS
Counts per
minute x 10
(day 3)
Polyclonal
response
TNP-PFC/106
(day 3)
Inducedresponse
(day 4)
No SRBC
to SRBC
SRBC
No LPS 1.92 <10 <10 <10
LPS alone 75.17 544 98 440
1 x 10
6 MDBcAMP < 1.0 <10 <10 <10
5 x 10
4 MDBcAMP 46.40 320 50 210
1 x 10 4 MDBcAMP 81 .20 440 90 490
5 x 10 ' MIsoproterenol <1.0 <10 <10 <10
1 x 10 ' MIsoproterenol 30.71 454 47 220
1 x 10 6 MIsoproterenol 76.17 468 68 520
1 x 10
3 M 5'AMP 68.20 510 90 400
5 x 10-1 M 5'AMP 71 .40 490 70 480
1 x 10-' M 5'AMP 72.90 560 84 416
1 x 10 ' McGMP 74.10 540 102 390
5 x 10
4 MCGMP 78.20 590 90 460
1 x 10 4 MCGMP 79.50 460 80 510
1 x 10- 3 M Carbachol 93.73 647 90 560
5 x 10-'M Carbachol 98.88 670 84 620
1 x 10 " M Carbachol 79.67 614 104 490104
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TABLE IV
Effect of Cyclic Nucleotides on DNA Synthesis in Nude Spleen Cultures
a
U
12,000
9p00
6P00
3,000
Nude spleen cells were cultured at a density of 5 x 108 cells/ml with the agents described above. After
24 h cells were incubated for a 6-h period with radioactive thymidine and the incorporation measured
as described in the Materials and Methods. Each figure represents the counts per minute
incorporated per culture and is the mean of triplicate cultures.
CYCLIC GMP
FIG. 2 .
￿
Mitogenic effects of cyclic GMP. Nude spleen cells were cultured at a density of 5 x
108 cells/ml with the concentrations of cyclic GMP indicated. At 24, 48, and 72 h DNA
synthetic responses were measured as described in the Materials and Methods. Each
point represents the mean of triplicate cultures.
in the intracellular levels of cyclic AMP inhibit the induction of primary immune
responses to SRBC in C57BL/6 spleen cultures (14, 15). Dibutyryl cyclic AMP,
monobutyryl cyclic AMP, cyclic AMP, but not 5' AMP, all inhibit the induction
of immune responses in the range of 10- " M-10-3 M, indicating that it is cyclic
AMP and not one of its various metabolites that is responsible for the inhibition.
At concentrations between 10 -5 M and 10-s M cyclic AMP and its butyrated
derivatives have an enhancing effect on the induction of immune responses (14,
15). Cyclic GMP or agents that stimulate increases in intracellular cyclic GMP in
lymphoid cells have little effect in the same concentration ranges on the
induction of immune responses to SRBC in C57BL/6 spleen cultures (14, 15) .
Concen-
tration
Dibu-
tyryl
cyclic
GMP
Mono-
butyryl
cyclic
GMP
Cyclic
GMP
5'GMP
Car-
bachol
Dibu-
tyryl
cyclic
AMP
Mono-
butyryl
cyclic
AMP
Cyclic
AMP
Isopro-
terenol
M
None 3,020 3,140 3,360 3,090 3,246 2,706 2,800 2,970 2,780
1 x 10-' 7,580 13,952 12,714 7,640 3,410 < 200 < 200 340 < 200
5 x 10-" 9,633 15,704 14,974 9,120 3,350 < 200 < 200 649 < 200
2 x 10-' 10,026 15,000 11,476 8,969 3,560 460 656 1,948 757
1 x 10-" 9,452 8,456 9,660 8,576 3,080 1,894 892 2,850 1,082
5 x 10- 5 3,503 3,110 4,137 4,077 2,970 1,850 2,408 2,787 1,975
1 x 10- 5 3,200 3,261 3,442 3,352 2,990 2,950 3,030 3,250 2,543JAMES WATSON
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TABLE V
Autoradiography of Nude Spleen Cells Stimulated by Cyclic
GMP
Compound
￿
Labelednuclei
None
￿
1.0
1 x 10-'McGMP
￿
5.5
5 x 10-'M cGMP
￿
10.8
2 x 10-'M cGMP
￿
6.1
1 x 10'M eGMP
￿
3.0
25 Ag LPS
￿
19 .6
Nude spleen cells were cultured at a density of 5 x 108 cells/ml with the
agents described above. After 24-h cultures were incubated for 10 h with
0.5 ACi [3H]thymidine and examined autoradiographically as described in
the Materials and Methods. The figures presented are the percent of
nuclei with more than 20 grains averaged from atotal of600-1,000counted
cells.
The addition of cyclic GMP to nude (T-cell depleted) spleen cultures has been
reported to have two effects on the induction of primary immune responses to
SRBC (14, 15). In the absence of SRBC small background immune responses to
SRBC are observed. In the presence of SRBC there is a definite synergistic effect
resulting in stimulations of immune responses abovethe background response. In
many experiments these stimulations consistently fall in therange of threefoldto
fivefold above the responses detected in cultures lacking SRBC . 5' GMP also
shows some stimulation of immune responses to SRBC in nude spleen cultures
(14, 15) . Cyclic AMPshows no stimulation of immune responses to SRBC in nude
spleen cultures in similar concentration ranges (14) .
Discussion
The addition of mitogenic concentrations of LPS to mouse spleen cultures
stimulates rapid but transient increases in the intracellular levels of cyclic GMP
with little concomitant change in cyclic AMP levels (Fig . 1 and Table 1) . The
increases in cyclic GMP levels are generally in the range of threefold to fivefold
and reach a maximum at 5-20 min and then decrease to a level that is generally
slightly higher than levels observed in nonstimulated cultures. Cyclic GMP
itself stimulates DNA synthesis in mouse spleen cultures, which reaches a
maximum in our culture conditions 24 h after addition to cultures (Fig . 2 and
Tables IV and V). Spleen cells contain a mixture of cell types, but as it is
known that LPS stimulates DNA synthesis and cell division in B lymphocytes
(12-14), it is likely that LPS is stimulating cyclic GMP synthesis in B
lymphocytes. A survey of a variety of nondividing and dividing cell cultures has
shown that while the intracellular levels of cyclic AMP and cyclic GMP vary
from one cell type to another, there is a striking difference in the ratio of cyclic
AMP to cyclic GMPbetween nondividing and dividing cells (Table II). This ratio
is always high in nondividing cells, and much lower in dividing cells (Table II).106
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This was consistent in spleen cells, lymphoid and myeloid tumor cells, and 3T3
cells. These observations suggest that the rapid, transient elevation ofintracellu-
lar cyclic GMP levels may not be as important as a mitogenic signal, particularly
as the initiation of DNA synthesis is not detected some 12-14 h later (Fig. 1), as
the prolonged decrease in the ratio of cyclic AMP to cyclic GMP.
There is considerable evidence from other mammalian systems that cyclic
GMP is involved as an intracellular mediator in proliferative processes (14-19),
and that it is the ratio of intracellular cyclic AMP to cyclic GMP that actually
modulates proliferative processes (17). The lymphocyte mitogens concanavalin A
and phytohemagglutinin stimulate rapid increases in cyclic GMP levels in
peripheral blood lymphocytes, although the reported increases are significantly
higher than observed for LPS (16). Cyclic GMP stimulates DNA synthesis and
cell division in nondividing 3T3 cultures (17), and in rat lymphocyte cultures
(18). The addition of serum to 3T3 cells which have been maintained in a
nondividing state by serum deprivation results in rapid, transient changes in
cyclic GMP levels, followedby DNA synthesis some 18 h later (17). These reports
indicate that a change in cyclic GMP levels is an early event after the delivery of
a mitogenic stimulus to cells.
The mitogenic, polyclonal, and synergistic effects of LPS in mouse spleen
cultures were blocked by simultaneously adding to cultures agents that raise
intracellular levels of cyclic AMP (Table II1). It has been shown previously that
the addition of high concentrations of cyclic AMP to mouse spleen cultures for
short times ( <12 h) stimulates the induction of primary immune responses to
erythrocyte antigens, but that treatment for longer periods inhibits immune
responses (14, 15). The effect of cyclic AMP specifically on the activity of AFC
precursors, studied by incubating nude spleen cells for various times with cyclic
AMP-elevating agents, washing cultures, and challenging with erythrocyte
antigens and nontreated T cells, has yielded similar results (14, 15) . While there
are also conditions where cyclic AMP enhances immune responses (14, 15),
prolonged treatment of precursor cells with cyclic AMP leads to their inactiva-
tion. In contrast to these cyclic AMP effects, agents which enhance intracellular
levels of cyclic GMP in mouse spleen cultures fall into three categories: (a) cyclic
GMP which, at concentrations where cyclic AMP is inhibitory, stimulates DNA
synthesis (Tables IV and V) and immune responses to SRBC in T-cell-depleted
cultures (14, 15), but has no effect on immune responses in normal spleen
cultures (14); (b) cholinergic agonists such as carbachol that are nonmitogenic
(Table IV), but which may exert slight stimulatory effects on immune responses
to SRBC in T-cell-depleted cultures (14); and (c) LPS which has mitogenic,
polyclonal, and synergistic effects (Table III). A number of the cyclic GMP
effects require consideration. 5' GMP also has stimulatory effects on DNA
synthesis (Table IV) and immune responses (14). While 5' GMP has been
reported to have no effect on DNA synthesis in quiescent 3T3 cells (17), it has
been shown to stimulate DNA synthesis in human lymphocyte cultures (18). The
5' GMP effects may be due to a general enhancing effect that purines appear to
exert on mammalian cells (36). AlthoughLPS enhances intracellular cyclic GMP
levels, the addition of cyclic GMP to cultures does not have the same effect as
LPS. High concentrations of cyclic GMP stimulate DNA synthesis reaching aJAMES WATSON
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maximum earlier than does LPS (Fig. 2) . Cyclic GMP does not stimulate
polyclonal responses as does LPS, and has smaller mitogenic and synergistic
effects in T-cell-depleted cultures (14) . There are a number of reasons why cyclic
GMP may have limited activity : it is unstable in culture having a half-life in
culture of approximately 60 min, and it gives rise to metabolites, particularly
guanosine, which exert inhibitory effects on growth . It is not known how
efficiently cyclic GMP is taken up by cells. It has not been possible to measure
accurately changes in the intracellular levels of cyclic GMP in the presence of
high concentrations of extracellular cyclic GMP, thus it is difficult to directly
compare the changes that occur intracellularly aftertreatmentwith LPS or cyclic
GMP. While these data show that an increase in cyclic GMP levels is required to
initiate proliferative events in nondividing cells, they also show that agents that
raise intracellular levels of cyclic GMP are not necessarily mitogenic. For
example, carbachol is not mitogenic (Table IV). As discussed above, the
transient increase in cyclic GMP levels in spleen cells after LPS stimulation may
not be as important to cells as the prolonged elevation which remains slightly
above the background (Fig. 1). For a cell to continue on a proliferative path-
way, the ratio of cyclic AMP to cyclic GMP may have to be lowered and main-
tained within definite limits. LPS and cyclic GMP may be mitogenic because
of their long-term effects on this intracellular ratio, whereas agents such as
carbachol may not have the prolonged effect on intracellular levels of cyclic
GMP required for an agent to be mitogenic.
Both cyclic GMP and carbachol, however, have an effect that is not shared by
LPS. It has been previously shown (14, 15), that the inactivating effect exerted by
agents that raise intracellular levels of cyclic AMP on the induction of in vitro
immune responses, is partially or completely prevented by the simultaneous
presence of cyclic GMP or carbachol. Attempts to reverse these cyclic AMP
effects with LPS have failed, but this may be due to changes in the immune
responsiveness of lymphoid cells after prolonged LPS treatment (28) .
An AFC precursor is a cell that is committed to respond to antigen in several
very different ways: by maturation to AFC (proliferation), or by inactivation (see
introduction) . The data reported here suggest that the intracellular ratio of cyclic
AMP to cyclic GMP is important in regulating the proliferative response of a
lymphoid cell, and the question follows then as to whether this ratio also
regulates the inactivation pathway in precursor cells.
Agents that elevate cyclic AMP levels in cells inactivate precursor cells in a
period of some 20-30 h (14, 15). Since the maturation of precursor cells to AFC
requires cell proliferation, and cyclic AMP is known to inhibit proliferation in a
variety of normal and malignant cell cultures (20-23), it is not surprising that
these various agents inhibit the induction of antibody synthesis. Thus, the
problem is whether to regard the inactivation of precursor cells by cyclic AMP as
merely a nonspecific toxic effect, or to regard this inactivation as a consequence
of a specific cyclic AMP-induced biochemical pathway. There are a number of
indirect reasons that favor inactivation via aspecialized cell pathway. While high
concentrations of cyclic AMP inhibit the growth of other mammalian cell types,
the inhibitory effects tend to be reversible for considerable periods (21-23) . These
high concentrations of cyclic AMP also cause the expression of differentiated108
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functions characteristic of specialized cells (24-26). For example, the addition of
high concentrations of cyclic AMP, or agents that raise intracellular levels of
cyclic AMP, induce the expression of thymus cell-specific antigens on immature
lymphocytes (24) . Also tumors derived from T lymphocytes have been found
which are rapidly killed by raising intracellular levels of cyclic AMP, not merely
growth arrested as are other mammalian cells (26) . Since such lymphoid tumors
are rapidly killed, rather than growth inhibited by cyclic AMP, it is believed that
cyclic AMP induces an inactivation process that is a specialized pathway in
lymphoid cells (26) . The inactivation of precursor cells by cyclic AMP is partially
or completely prevented by the simultaneous presence of cyclic GMP (14, 15).
This may not be expected if the inactivation process is due to a general toxic
effect. It is unlikely that cyclic GMP is merely competing with cyclic AMP for
uptake into cells to reduce the effective intracellular concentration of cyclic AMP
in these experiments as carbachol, the cholinergic agonist, reverses the inactivat-
ing effects of both cyclic AMP and isoproterenol, the beta-adrenergic agonist
(14) . The intracellular levels of cyclic AMP are not affected by carbachol and
possibly not by cyclic GMP in those reversal experiments (14), thus the reversal
effects indicate it is not the absolute level of intracellular cyclic AMP that leads
to inactivation, rather it is the intracellular ratio ofcyclic AMPto cyclic GMP.
The interaction of haptenic determinants with surface immunoglobulin
receptors on precursor cells initiates events that lead to their inactivation (see
introduction). I suggest that this interaction may lead to the activation of adenyl-
ate cyclase and a subsequent increase in cyclic AMP levels. This increase, de-
tected by the cell by the increase in the ratio of cyclic AMP to cyclic GMP initi-
ates the biochemical events that constitute the inactivation pathway. This
process may take some 20-30 h for completion to give time for the T cells to de-
liver a signal to precursor cells allowing cells to then proceed, to an inductive
pathway (see introduction). I suggest that the T-cell signal activates guanylate
cyclase. The subsequent increase in the intracellular cyclic GMP level decreases
the ratio of cyclic AMP to cyclic GMPand leadsto a proliferative pathway.
The external signals that constitute inductive or paralytic stimuli may be
mediated at the cell surface via the activation of the enzymes that synthesize
cyclic AMP and cyclic GMP in cells. The changing ratio of these cyclic
nucleotides may determine which pathway a cell will follow. Little is known of
the steps involved in the activation of adenylate or guanylate cyclases after the
binding of ligands to cell surface receptors, or of the metabolic pathways that
may be regulated by changes in the intracellular ratio of cyclic AMP to cyclic
GMP. Since this ratio can be altered in a number of ways, by increasing cyclic
GMP, by decreasing cyclic AMP, or by differentially increasing or decreasing
both, it is important to determine whether the ratio can be altered in only one
or a variety of ways to initiate proliferation or inactivation pathways. For ex-
ample, does initiation of the inductive pathway require the delivery of two mem-
brane-mediated signals? Is an increase in the absolute level of both cyclic AMP
and cyclic GMP, as well as a decrease in theirratiorequired?
These data may also reflect the mode of action of polyclonal B-cell mitogens
(12, 13). The evidence using LPS and other B-cell mitogens has been interpreted
that a single mitogenic signal is sufficient to induce both the maturation of AFC,
and also their inactivation (12, 13). As LPS elevates cyclic GMP levels (Fig. 1), aprolonged increase in cyclic GMP levels may be all that is required to stimulate
maturation to AFC. Other polyclonal mitogens may function in this manner (12,
13) to initiate cell proliferation . This raises the question of whether the T-cell
signal alone is sufficient to induce antibody synthesis. There is a fundamental
difference between the action of polyclonal mitogens on one hand, and antigen
and specific T cells, on the other, on individual precursor cells. Polyclonal
mitogens appear to restrict most responding cells to only several division cycles
(12, 13), however, antigen and specific T-helper cells stimulate cells to undergo
many more division cycles (28) . Perhaps this difference reflects a requirement for
an elevation of cyclic AMP to enable lymphoid cells to maintain their prolifera-
tive capacity via a more mitogenic cyclic AMP to cyclic GMP ratio.
Summary
The intracellular ratio of adenosine 3',5'-cyclic monophosphate (cyclic AMP) to
guanosine 3',5'-cyclic monophosphate (cyclic GMP) may control the develop-
mental pathway followed by antibody-forming cell (AFC) precursors. The
evidence for this is derived from several different types of experiments. First
lipopolysaccharide (LPS) which is mitogenic for B lymphocytes, stimulates
rapid, transient changes in intracellular levels of cyclic GMP but notcyclic AMP
when added to mouse spleen cultures. Cyclic GMP itself stimulates DNA
synthesis in these cultures, suggesting that the intracellular changes in cyclic
GMP levels are involved in the mitogenic signal delivered by LPS to cells. The
absolute amounts of cyclic nucleotides may vary widely in different cells under
various conditions, however, the intracellular ratio of cyclic AMP to cyclic GMP
is always high in nondividing cells and low in dividing cells. AFC precursors
appear to respond to antigen in the absence of T-cell activity by inactivation
(1-7). In the response to antigen in the presence of specific T cells, precursor cells
proliferate and mature to AFC. Raising intracellular levels of cyclic AMP inhibits
cell proliferation and leads to precursor cell inactivation (14, 15). It is suggested
that the interaction of antigen with immunoglobulin receptors on the surface of
precursors cells leads to the stimulation of adenylate cyclase activity andinitiates
the inactivation pathway. Since cyclic GMP stimulates immune responses in
T-cell-depleted cultures (14, 15) and increasing cyclic GMP levels appear to be
involved in the delivery of a mitogenic signal to cells, it is suggested that T-helper
cells deliver a signal to precursor cells via the stimulation of guanylate cyclase to
initiate the inductive pathway. It is suggested that it is the intracellular ratio of
cyclic AMP to cyclic GMP that regulates the fate of precursor cells, not the
absolute level of one cyclic nucleotide.
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